TrumpRx: A Major Step Toward Lower Prescription Drug Prices

Washington, D.C.—The America First Policy Institute (AFPI) offered the following statement from Hannah Anderson, Senior Director of Policy and Director of Healthy America:

“President Trump knows that putting patients before middlemen is the only way to lower prescription drug costs. TrumpRx is the first of its kind platform to show the no-middleman cost of different drugs, allowing patients to purchase drugs without adding 40% to the cost in middleman fees.

TrumpRx allows Americans to access medicine directly from manufacturers at Most Favored Nation pricing. That means Americans will no longer be subject to global freeloading when it comes to some of their most commonly-prescribed drugs.

AFPI applauds President Trump’s commitment to delivering savings for American patients and holding the pharmaceutical industry accountable to fair, global pricing standards.”